Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PRCY - ANY BODY HAS ANY NEWS ON THESE -- Ignore unavailable to you. Want to Upgrade?

To: Douglas who wrote (412)	11/4/1998 7:33:00 PM
From: tom jones	Respond to of 670

To all: Procyte thoughts and questions. Does anyone know how big Advocare is or how much revenue Procyte expects to make from sales to Advocare? Management may repurchase stock to raise PRCY stock to over $1. This may not be a bad plan because they have $8 million in cash and they could just spend $4 to buy 6 to 8 million shares. If the price doesn't go over $1 or falls below $1 later it would only take a few million by insiders to take the company private. A reverse split could do the same thing (company doesn't spend any money) but insiders have bought about 100,000 shares this year and may not want to have their own shares decrease. The companies Procyte is merging and dealing with have stakes in PRCY also. Anyway something will happen before Christmas. Comments? Tom